{"entity":{"id":"nct05678998","kind":"trial","name":"WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma","aka":[],"tldr":"A phase 1 trial of WTX-330 run by Werewolf Therapeutics, Inc., completed.","summary":"WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma is a phase 1 interventional study registered as NCT05678998 by Werewolf Therapeutics, Inc., with 25 participants enrolled, started 2022-12-06. Conditions recorded: Advanced or Metastatic Solid Tumors and Non-Hodgkin Lymphoma. Interventions recorded: WTX-330.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT05678998","url":"https://clinicaltrials.gov/study/NCT05678998"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer","non-hodgkin-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":["wtx-330"],"companies":["werewolf-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05678998","phase":"1","setting":"A Phase 1 (First-In-Human [FIH]), Multi-Site, Dose Escalation and Expansion Study of WTX-330 in Adult Patients With Advanced or Metastatic Solid Tumors or Lymphoma","sponsor":"Werewolf Therapeutics, Inc.","enrolled":25,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05678998/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"},{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"drug":[{"id":"wtx-330","kind":"drug","name":"WTX-330","route":"/drugs/wtx-330/"}],"company":[{"id":"werewolf-therapeutics","kind":"company","name":"Werewolf Therapeutics","route":"/companies/werewolf-therapeutics/"}]}}